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INTRODUCTION
 International Urogynecological Association 
(IUGA)1 defines SUI as involuntary loss of urine 
on effort causing a rise in abdominal pressure. It 
has a severe impact on the quality of life (QOL) 
of a significant number of women.2 Among adult 
women, its prevalence varies from 12.8% to 46.0%.3 
 After failed conservative management, surgery 
is considered a standard treatment 4 with the aim to 
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ABSTRACT
Objectives: To compare the effectiveness and complications of Burch colposuspension and Mid Urethral 
Slings (MUS) for the treatment of Stress Urinary Incontinence (SUI).
Methods: We conducted a cross-sectional study of 162 patients who underwent surgery for SUI with Burch 
colposuspension (n=40), tension free vaginal tape (TVT) (n= 59) or transobturator tape (TOT) (n=63), 
from 2006 to 2014 at the Aga Khan University Hospital- Karachi. All three groups were assessed in terms 
of demographics, cure rates, intraoperative and postoperative complications at one and five years using 
incontinence impact questionnaire-short form-7 (IIQ-7) and urogenital distress inventory -short form-6 
(UDI-6).
Results: Mean age of the participants in Burch, TVT and TOT group was 44.1 ± 7.4, 48.3 ± 8.9, 53.0 ± 9.4 
respectively. Majority of patients in TVT group were premenopausal (59.3%) and postmenopausal in TOT 
group (53.9%). Most abdominal hysterectomies were done in Burch group (40) while vaginal hysterectomies 
and anterior and posterior colporrhaphy in TOT group (55). All the procedures had both subjective and 
objective cure rate of more than 82% at one year, with TVT having the highest success rate of 96.61%. The 
objective cure rate in Burch, TVT and TOT group at five years was 74.19%, 90.30% and 81.25% respectively. 
Intraoperative complications included hemorrhage in one patient during Burch procedure and bladder 
perforation in two cases of TVT, with no significant difference in short or long-term complications with 
either procedure.
Conclusions: All the three procedures have equal efficacy and complication rates. Even though TVT is the 
new gold standard but in view of current debate regarding mesh related complications, there is a need to 
readdress Burch colposuspension for treatment of SUI.
KEYWORDS: Burch colposuspension, Tension free vaginal tape, Transobturator tape, Long-term results, 
Stress urinary incontinence.
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stabilize urethrovesical junction. Various surgical 
methods are performed but the ideal procedure 
has still not been defined. Burch colposuspension 
described in 1961, as a gold standard surgical 
treatment of SUI in terms of efficacy and safety.5 
Later TVT became the new gold standard, because 
of being minimally invasive but equally good 
success rates.6 In 2001, Delorme introduced the 
TOT procedure with the aim to avoid bladder, 
bowel, and major vascular injuries, reported with 
other retro-pubic sling techniques.7
 Numerous studies have compared the efficacy of 
Burch colposuspension and MUS. A meta-analysis 
of colposuspension and MUS demonstrated 
significantly higher overall and objective cure 
rates with MUS but a higher risk of bladder 
perforation in retropubic slings as compared to 
TOT.8 A regional study from Turkey showed that 
TOT is associated with improved objective cure 
rates of SUI and QOL.9 Similarly a local study from 
Pakistan revealed that TVT is an effective and safe 
procedure for the surgical treatment of SUI.10
 The use of MUS in Asia is less than Western 
countries. In India MUS is used by about 60% 
surgeons as primary surgery for SUI while Burch 
colposuspension is the second choice among 
the other Asian countries,11 however there is no 
study done in Pakistan, which has compared all 
the three procedures.
 Since the Food and Drug Administration Public 
Health issued a Notification regarding safety of 
transvaginal mesh in 2011,12 there has been debate 
regarding safety of MUS procedures. There is a dire 
need to readdress the use of Burch colposuspension, 
which has now become a forgotten skill for 
surgical treatment of SUI. This study was aimed 
to compare Burch colposuspension with MUS in 
terms of efficacy and complication rates.
METHODS
 We conducted a cross-sectional study of 162 
women, aged 30 to 70 years who underwent either 
Burch colposuspension, TOT or TVT for diagnosed 
SUI at the Aga Khan University Hospital. ICD-
9-CM procedure codes were used to determine 
these procedures, from January 2006 till December 
2014. At our hospital, standard definition and 
classification for the urodynamic studies (UDS) 
and SUI grades are used in compliance with ICS/
IUGA terminology.
 All three groups were compared in terms of 
demographic and clinical characteristics (age, 
body mass index (BMI) and parity), concomitant 
surgical procedure, type of surgical procedure, 
short and long term complications. All patients 
were evaluated by history, Urogynecological 
clinical examination, urinalysis and urine culture. 
The type of SUI was established on basis of 
clinical symptoms, objective stress test (the test 
was considered positive if patient leaked urine in 
supine position on coughing after their bladder 
were filled with 300ml of saline) and UDS. UDS 
was performed by urodynmicist nurse, before 
surgery in all cases of Burch colposuspension to 
rule out intrinsic sphincter deficiency (ISD) while 
in a few cases of mixed urinary incontinence to 
exclude neurogenic bladder preoperatively. All 
women with neurogenic bladder, history of anti-
incontinence surgery, pregnancy, patients on 
antipsychotic medications and those who were 
lost to follow-up were excluded from the study. 
 The same surgeon performed all the procedures. 
Foley catheter was retained for 24 hours after MUS 
group and 36–48 hours postoperatively in the 
Burch group. 
 All patients were followed-up at 2 and 6 weeks, 
6 months, 1 year, 5 years and thereafter data 
was collected by telephonic conversation. Post 
operatively all patients were re-evaluated using 
incontinence impact questionnaire-short form-7 
(IIQ-7) and urogenital distress inventory -short 
form-6 (UDI-6) for improvement in health-related 
QOL. Response to each item was originally rated 
between 0 (not affected at all) and 3 (greatly affected). 
Postoperatively the patients were regarded as 
cured if they had negative stress test results and if 
QOL assessed using IIQ-SF 7 scores showed >90% 
improvement and improved if the patient was 
having > 75% improvement in symptoms.13
 The intraoperative and postoperative 
complications like bowel and bladder injury, 
hemorrhage, urinary retention, hematoma, 
prolonged hospital stay, voiding dysfunction 
and mesh related complications like exposure, 
erosion, infection and rejection were recorded for 
all patients.
 Entry of data and analysis were done using SPSS 
version 21. The data from the various groups (Burch 
colposuspension, TVT, TOT) were compared using 
the chi-squared test for categorical variables, and 
ANOVA for parametric quantitative variables. 
P-value < 0.05 were considered statistically 
significant.
Ethical approval: Ethical approval for this study 
was taken from institutional Ethical Review 
Committee (5017-Obs-ERC -17).
Pak J Med Sci     September - October  2021    Vol. 37   No. 5      www.pjms.org.pk     1361
RESULTS
 Our study evaluated 63 patients in TOT, 59 
patients in TVT and 40 patients in the Burch 
colposuspension group. There was no statistically 
significant difference in baseline demographics 
and clinical characteristics among the three 
groups other than age and menopausal status 
(Table-I). The only confounding variables were 
total abdominal hysterectomy and bilateral 
salpingectomy performed in all cases of Burch 
colposuspension, concomitant anterior and 
posterior colporraphy performed with TVT, TOT 
and few cases of Burch colposuspension and 
vaginal hysterectomy in certain cases of TOT 
and TVT (Table-II). It is a routine practice in our 
unit to perform Burch colposuspension for SUI, 
in whom abdominal hysterectomy is planned for 
gynecological conditions. 
 The incidence of perioperative complications 
are sown in Table-III. Only one patient had 
intraoperative hemorrhage during Burch 
procedure and 2 patients had intraoperative 
bladder perforation during TVT (2.5%). There were 
no significant short or long-term complications 
with either procedure.
Table-I: Demographic and Clinical Characteristics of Study Population=n=162.
Parameter Burch (n=40) TVT (n=59) TOT (n=63) P value
Age, years 44.1 ± 7.4 48.3 ± 8.9 53.0 ± 9.4 0.001
Parity 4.4 ± 2.1 4.3 ± 2.4 4.3 ± 2.2 0.991
Body mass index (kg/m2) 31.1 ± 8.0 28.7 ± 4.7 30.3 ± 5.5 0.116
Mean follow-up (months) 38 (30-60) 36.5 (28-60) 36.7 (28-60) 0.11
Comorbidity
Hypertension 12 (30.0%) 18 (30.0%) 24 (38.0%) 0.590
Diabetes mellitus 8 (20.8%) 17 (28.8%) 22 (34.9%) 0.305
Pulmonary disease 10 (25.0%) 20 (33.8%) 16 (25.0%) 0.400
Constipation 5 (12.5%) 7 (11.8%) 16 (25.3%) 0.092
Menopausal status
Premenopausal 15 (37.5%) 35 (59.3%) 13 (20.6%)
0.000
Postmenopausal 4 (10.0%) 21 (35.5%) 34 (53.9%)
Abbreviations: TOT, transobturator tape; TVT, tension free vaginal tape, Data are mean ± SD or n= (%).
Table-II: Details of Procedure and Type of Incontinence.
Procedures Burch (n=40) TVT (n=59) TOT (n=63)
Anti-incontinence surgery alone 0 (0) 11 (18.6%) 2 (3.1%)
Vaginal Hysterectomy 0 (0) 26 (44.0%) 55 (87.3%)
Abdominal Hysterectomy 40 (100%) 21 (35.6%) 5 (7.9%)
AP repair 3 (7.5%) 33 (55.9%) 44 (69.8%)
Mean duration of catheterization 3.9 ± 2.2 2.2 ± 0.7 1.8 ± 1.3
Urodynamic studies 40 (100%) 50 (84.7%) 29 (46.0%)
ISD 0 (0) 12 (20.3%) 12 (19.0%)
MUI 4 (10.0%) 7 (11.8%) 26 (41.2%)
Abbreviations: TOT, transobturator tape; TVT, tension free vaginal tape; ISD, Intrinsic sphincter deficiency; 
MUI, Mixed urinary incontinence; AP repair, Anterior and Posterior repair.
Treatment of Stress Urinary Incontinence
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 The subjective and objective cure rates of SUI 
after one and five years are shown in Table-
IV. There was no significant difference in the 
subjective and objective cure rates of SUI for 
all these procedures both at one and five years 
follow-up. For analysis of cure rates at the end 
of five years, 32 patients were available in the 
TOT group, 42 in TVT group and 31 in the Burch 
group. Seven patients in the TOT group were 
incontinent by the end of 1 year: medical therapy 
was commenced in four patients while three 
patients were re-operated on and TVT procedure 
Saida Abrar et al.
Table-III: Surgical and Functional outcomes in the Study Patients.
Outcome Burch (n=40) TVT (n=59) TOT (n=63) P value
Intra-Operative complications
  Hemorrhage 1 (2.5%) 0 (0) 2 (3.1%) 0.364
  Bladder injury 0 (0) 2 (3.3%) 0 (0) 0.192
  Bowel injury 0 (0) 0 (0) 0 (0) 0
  Neurovascular injury 0 (0) 0 (0) 0 (0) 0
Postoperative early complications (within 7 days of surgery)
  Prolong length of hospital stay 2 (5%) 1 (1.69) 0 (0) 0.212
  Perineal hematoma 0 (0) 0 (0) 1 (1.58) 0.441
  Extended antibiotics 5 (12.5%) 2 (3.3%) 5 (7.9%) 0.056
  Shift to special care 1 (2.5%) 0 (0) 0 (0) 0.025
  Urinary retention 5 (12.5%) 2 (3.3%) 0 (0) 0.152
Postoperative late complications (>2 weeks of surgery)
  Wound infection 3 (7.5%) 0 (0.0) 0 (0) 0.063
  Mesh Exposure 0 (0) 2 (3.4) 4 (6.3%) 0.196
  De novo Urgency 1 (2.5%) 1 (1.7%) 0 (0) 0.531
  Short-term Voiding Dysfunction 2 (5%) 1 (1.7%) 0 (0) 0.212
Compartment defects > one year
  Enterocele 1 (2.5%) 0 (0) 0 (0) 0.235
  Cystocele 2 (5%) 2 (3.4%) 3 (4.7%) 0.866
Abbreviations: TOT, transobturator tape; TVT, tension free vaginal tape.
Statistical tests: chi-squared and ANOVA. Data are n/N (%) unless otherwise specified.
Table-IV: Cure rates on Stress Urinary Incontinence (SUI) at 1 and 5 years.
Variable                                                     Burch (n=40) TVT (n=59) TOT (n=63) p-value
Cure rates at 1 year                  
   Subjective 









Cure rates at 5 years
   Subjective









Abbreviations: TOT, transobturator tape; TVT, tension free vaginal tape
Values are given as number (percentage) unless otherwise indicated.
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was performed. The TVT slings were placed 
without removing TOT sling. De novo urge 
incontinence developed in one patient in the TOT 
group. Ten patients were incontinent in the Burch 
group: six patients received medical treatment 
while four patients were re-operated on with the 
TVT procedure. Urinary retention was observed 
in one patient in the TOT group.
DISSCUSION
 Our study showed almost similar objective and 
subjective success rates and complications with 
all the three procedures for treatment of SUI at 
one and five years follow-up. This is in contrast 
to a meta-analysis,14 which showed that MUS had 
significantly higher overall and objective cure 
rates compared with Burch procedures (odds 
ratios [OR] 0.59 and 0.51, respectively; both p < 
0.0003).
 A retrospective study of Burch colposuspension 
(n = 498) vs. TOT (n = 272) showed similar five 
year cure rate for both groups, however, fewer 
patients developed De-novo urgency or required 
self-clean intermittent catheterization (CISC) in 
TOT group than Burch colposuspension.15
 The current study showed 3.4% risk of bladder 
perforation only in TVT group while nine 
trials comparing these three procedures found 
bladder perforation of 6% in TVT versus 1 % in 
open colposuspension (RR 4.24, 95% CI: 1.71--
10.52).16 The risk factors associated with bladder 
perforation in our study were same as reported 
in literature i.e., high BMI and previous pelvic 
surgery.17,18 
 We found 5% Voiding Dysfunction (VD) in 
Burch and 1.7% in TVT group, similar to results 
observed in a recent systematic review.14 A 
similar retrospective study found 6.1% short term 
VD with TVT and 7.9% with Burch16 but among 
the MUS; TVT was associated with long-term-
VD.19 However we did not observe any long-term 
VD in MUS requiring tape resection, removal 
or CISC. In line with the current study, a recent 
randomized trial showed a small, non-significant 
difference in VD (21.8% versus 27.6%) in cases 
of TOT versus TVT respectively.20 This fact may 
be explained by the horizontal position of the 
sling that minimized the possibilities of urethral 
compression.
 The frequency of de-novo urgency urinary 
incontinence (UUI) was higher in colposuspension 
than in MUS which is similar to long-term follow 
up study reporting de novo UUI ranging from 15-
41% after Burch,18 4-17 after TVT 20-22 and 1.5- 6.7% 
with TOT.20
 We did not observe any long-term mesh related 
complication, however asymptomatic tape 
exposure was seen with TVT (3.4%) and TOT 
(7.1%) but there was no statistically significant 
difference. Studies on MUS have reported mesh 
related long-term complication including vaginal 
tape erosion/extrusion rate as 1.5% and 0.4% 
with TVT and TOT respectively and urethral 
erosions and sexual dysfunction like dyspareunia 
or hispareunia after MUS.22-24 Our study showed 
2.5% enterocele and 5% cystocele at five years 
follow-up with Burch colposuspension while 
literature shows it in range of 1-34%.25
Strength of the study: The strength of our study 
includes long term follow up, the exclusion of ISD 
for Burch colposuspension by prior UDS and one 
surgical hand.
Limitations of the study: The limitations of 
study include the retrospective data of one center 
with small number of patients in each group. 
We performed Burch colposusspension only for 
urethral hypermobility and hence results for ISD 
cannot be compared.
CONCLUSION
 The surgical outcome of these three procedures is 
comparable with almost similar complications and 
cure rates of SUI. In the current era of controversy 
regarding the use of mesh and its associated 
complications, Burch colposuspension could be a 
useful alternate for the surgical treatment of SUI.
Source of funding: None.
Disclosure Statement: None.
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